文献速递胃肠外科围术期管理与 ERAS

袖状胃切除与胃旁路术后糖尿病药物停用的独立预测因素

Independent Predictors of Discontinuation of Diabetic Medication after Sleeve Gastrectomy and Gastric Bypass.
PubMed 文献 · J Am Coll Surg · 2022-09-15

基于全州减重手术登记数据,纳入2006至2019年接受袖状胃切除或胃旁路的11664例术前用药患者。术后1年口服药停用率85.7%、胰岛素停用率66.6%;胃旁路是胰岛素停用的独立预测因素,但两种术式口服药停用无差异,且胃旁路风险调整后并发症率更高。

要点

  • 术后1年口服降糖药停用率85.7%,胰岛素停用率66.6%。
  • 胃旁路是胰岛素停用的独立预测因素(OR 1.17)。
  • 胃旁路风险调整后并发症率显著高于袖状胃切除。

核心结论

  • 需胰岛素治疗的患者胃旁路术后胰岛素停用率更高,但并发症率也显著高于袖状胃切除。
  • 仅口服药治疗者术后1年停药率超过85%,且术式类型不能预测停药。
  • 疾病严重程度是选择术式时的重要考量因素。

研究设计与样本

  • 使用全州减重手术特异性数据登记,回顾性评估2006至2019年接受袖状胃切除和胃旁路的患者。
  • 纳入术前仅口服降糖药或使用胰岛素且完成1年随访者,共11664例。
  • 采用多因素回归识别口服药或胰岛素停用的独立预测因素,并比较两种术式风险调整后并发症率。

主要发现

  • 术后1年85.7%患者停用口服降糖药,66.6%停用胰岛素。
  • 胃旁路是胰岛素停用的独立预测因素(OR 1.17;CI 1.01至1.35;p=0.0329)。
  • 术式类型与单纯口服药停用无关联。
  • 胃旁路风险调整后并发症率显著高于袖状胃切除:口服药组11.2% vs 4.8%(p<0.0001),胰岛素组12.0% vs 7.4%(p<0.0001)。

临床怎么用

  • 对需胰岛素治疗的糖尿病患者,胃旁路可能提高胰岛素停用机会,但需权衡更高并发症风险。
  • 对仅口服降糖药者,两种术式1年停药率均超过85%,术式选择可不以停药预测为依据。
  • 决策时应结合糖尿病严重程度(是否使用胰岛素)个体化选择术式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both gastric bypass and sleeve gastrectomy can induce diabetes remission. However, deciding which procedure to perform is challenging, because remission rates and morbidity can vary, depending on patient factors as well as disease severity. STUDY DESIGN: Using a statewide bariatric-specific data registry, we evaluated all patients undergoing sleeve gastrectomy and gastric bypass between 2006 and 2019 who reported taking either oral diabetic medication alone or who were on insulin before surgery and who also had 1-year follow-up (n=11,664). Multivariate regression was used to identify independent predictors for discontinuation of oral diabetic medication or insulin, respectively, and risk-adjusted complication rates were compared between procedure types among each group. RESULTS: At 1-year after surgery, 85.7% of patients reported discontinuation of oral diabetic medication and 66.6% reported discontinuation of insulin. Gastric bypass was an independent predictor for insulin discontinuation (odds ratio 1.17; CI 1.01 to 1.35; p = 0.0329); however, procedure type was not associated with discontinuation of oral medication alone. Risk-adjusted complication rates were significantly higher after gastric bypass than after sleeve gastrectomy, regardless of whether the patient was taking oral diabetic medications alone or was on insulin (11.2% vs 4.8%, p < 0.0001 and 12.0% vs 7.4%, p < 0.0001, respectively). CONCLUSIONS: Patients requiring insulin experience higher rates of insulin discontinuation after gastric bypass, but also have significantly higher complication rates when compared to sleeve gastrectomy. However, if patients are on oral diabetic medication alone, rates of medication discontinuation at 1 year are greater than 85% and procedure type is not predictive. Disease severity is an important factor when deciding on the optimal procedure for diabetes.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Varban OA, Bonham AJ, Carlin AM, et al. Independent Predictors of Discontinuation of Diabetic Medication after Sleeve Gastrectomy and Gastric Bypass. J Am Coll Surg. 2022. PMID: 35752876. doi:10.1097/XCS.0000000000000306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。